Open AccessFDA Encourages ODAC to Reject Genasense as CLL Treatment
Author(s) -
Margot J. Fromer
Publication year - 2006
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000303887.07873.9f
Subject(s) - medicine , fludarabine , clinical trial , cyclophosphamide , refractory (planetary science) , chronic lymphocytic leukemia , cancer , oncology , chemotherapy , leukemia , surgery , physics , astrobiology